Veristat Appoints Gabriela Rosu, M.D., as Senior Director of Global Medical Affairs Team

Veristat, the Science-First Full Service CRO and Consultancy announced that Gabriela Rosu, M.D., has joined as Senior Director of Global Medical Affairs. Dr Rosu is a seasoned professional with over twenty years of experience in scientific and clinical fields, having significantly contributed to the planning and execution of pivotal activities that have led to the approval […]

EMVision secures USD 10Mln investment from Keysight technologies

EMVision from L to R: Robert Tiller - Head of Design, Scott Kirkland - CEO and Managing Director holding the next-Gen first-responder concept, Forough Khandan – Chief Technology Officer and Christian Wight - Head of Regulatory Affairs, with emu™ brain scanner (center)

EMVision, an Australian medical device company focused on developing innovative portable brain imaging technology, has announced a US$10 million (~A$15.28m) strategic investment from Keysight Technologies, a global leader in test and measurement technology. The investment provides EMVision with a fully funded commercial runway for its emu™ device. It accelerates clinical trials, generating essential data supporting […]

Medable announces a partnership with Duke BASE Lab

Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials

Medable Inc., a leading technology provider for modern clinical trials, announces results from a new research project with Duke University Department of Population Health Sciences’ Bioethics and Stakeholder (BASE) Lab on the acceptability of enhanced electronic informed consent (eIC) in clinical trials. The pilot study* compared participant comprehension and usability, satisfaction, and preference of enhanced eIC […]

Buzzreach and Oncoshot announce collaboration

Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan

Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specializes in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform. The collaboration will extend to Oncoshot’s strategic contract research […]

Verily and OneOncology collaborate to advance cancer research

Verily and OneOncology Announce Collaboration to Advance Cancer Research

Verily, an Alphabet precision health technology company, and OneOncology, the national platform for independent oncology practices, have established a strategic partnership that will enable more efficient clinical trials. As part of the agreement, Verily will integrate its clinical trial management software (CTMS) platform, SignalPath, across practices in the OneOncology Research Network, OneR. SignalPath will enable sites […]

Vial appoints Emma C. Moran as the new VP of Central Nervous Systems

Emma C. Moran, Vice President of Central Nervous Systems (CNS), Vial

Vial, a global tech-driven CRO providing next-generation clinical trial management services, announced the addition of Emma C. Moran to their team. Moran will be the CRO’s new VP of Central Nervous Systems (CNS), bringing with her an impressive 28-year track record in the clinical research industry. Moran’s expertise spans various domains within the pharmaceutical sector, having worked with both […]

RQM+ takeovers Libra Medical

Margaret Keegan CEO RQM+

RQM+, one of the world’s leading MedTech service provider, yesterday announced the acquisition of Libra Medical, a full-service contract research organization (CRO) that specializes in early-stage clinical trials. Founded in 2007, Libra Medical provides regulatory affairs, clinical operations and quality assurance services to companies that develop complex medical devices and diagnostics products. Libra’s studies take […]

Rxilient Biotech and Junshi Biosciences partner to develop and commercialize Toripalimab

On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam. Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. […]